| Name | Title | Contact Details |
|---|
Headquartered in Austin, we started as a single store with a mission to deliver outstanding results for our customers by providing supplements with the best-in-class ingredients and putting the customer`s experience first. Now more than 10 years later, we have evolved into Defyned Brands, a product development, brand marketing, and multi-channel retail company, owning 5 lifestyle supplement brands and over 50 retail stores under the name 5 Star Nutrition. We are passionate about putting our customers first by helping them reach their health and wellness potential.
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.
American College Health Association is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Manta Scientific Solutions is a Highland Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.